Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Patent
1993-11-12
1995-04-18
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
436173, 424450, 514492, 514502, 514836, A61B 5055, A61K 3722
Patent
active
054076609
ABSTRACT:
Nuclear magnetic resonance (NMR) imaging of body organs and tissues is enhanced by administering to a living animal body a diagnostic composition comprising a diagnostically effective amount of a substantially nontoxic paramagnetic image altering agent containing a chelate of a paramagnetic element such as magnesium, gadolinium or iron, carried by a liposome. The chelate is carried by or within or outside the external surface of the liposome in such a manner that after arrival at or delivery to the desired organ or tissue site, the paramagnetic image altering agent is released in a diagnostically useful fashion.
REFERENCES:
patent: 4016290 (1977-04-01), Rahman
patent: 4647447 (1987-03-01), Gries et al.
Guilmette, R. A. et al. Life Sciences 22(4):313-320 (1978).
Perrin, D. D. et al. Pharmacol. Ther. 12:255-297 (1981).
Pulsieux, F. et al. Biomed. Pharmacother. 36:4-13 (1982).
Ryman, B. et al. Proc. Feb. Mett. 56(Mol. Dis.):79-88 (1978).
Bosworth Mark E.
Hopkins Ronald M.
Hollinden Gary E.
Mallinckrodt Medical Inc.
LandOfFree
Diagnostic liposomal compositions for enhancing NMR imaging does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnostic liposomal compositions for enhancing NMR imaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic liposomal compositions for enhancing NMR imaging will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-65136